Michael Matson
Stock Analyst at Needham
(2.63)
# 2,020
Out of 5,128 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $126.53 | +234.31% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $7.32 | +1,129.51% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $91.65 | -42.17% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $90.54 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $248.21 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $98.65 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $64.62 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $367.75 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $12.24 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $74.96 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $89.03 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.08 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.67 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $353.56 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $126.53
Upside: +234.31%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $7.32
Upside: +1,129.51%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $91.65
Upside: -42.17%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $90.54
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $248.21
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $98.65
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $64.62
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $367.75
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $12.24
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $74.96
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $89.03
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.08
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $3.67
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $353.56
Upside: -